CONTINUUS PHARMACEUTICALS

Serial Number 90379720
Registration 6689247
700

Registration Progress

Application Filed
Dec 14, 2020
Under Examination
Approved for Publication
Jan 18, 2022
Published for Opposition
Jan 18, 2022
Registered
Apr 5, 2022

Trademark Image

CONTINUUS PHARMACEUTICALS

Basic Information

Serial Number
90379720
Registration Number
6689247
Filing Date
December 14, 2020
Registration Date
April 5, 2022
Published for Opposition
January 18, 2022
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 5, 2022
Registration
Registered
Classes
040

Rights Holder

Continuus Pharmaceuticals, Inc.

03
Address
251 Little Falls Drive
Wilmington, DE 19808

Ownership History

Continuus Pharmaceuticals, Inc.

Original Applicant
03
Wilmington, DE

Continuus Pharmaceuticals, Inc.

Owner at Publication
03
Wilmington, DE

Continuus Pharmaceuticals, Inc.

Original Registrant
03
Wilmington, DE

Legal Representation

Attorney
Paul Garrity

USPTO Deadlines

Next Deadline
824 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220405)
Due Date
April 05, 2028
Grace Period Ends
October 05, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

18 events
Date Code Type Description Documents
Apr 5, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 18, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 18, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 29, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 13, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 7, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 7, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 7, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 7, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 18, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 17, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 17, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 15, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 15, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 15, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 7, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 21, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 17, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Custom manufacture of pharmaceuticals
First Use Anywhere: Feb 7, 2012
First Use in Commerce: Feb 7, 2012

Additional Information

Design Mark
The mark consists of the word CONTINUUS in capitalized bold lettering, with each adjacent letter U drawn with one continuous line, and the word PHARMACEUTICALS directly below in smaller lower case letters.

Classification

International Classes
040

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CONTINUOUS" AND "PHARMACEUTICALS"